Automation index

How much of a Penetration tester’s job can AI already do?

A scan and a template report come earlier. Finding the weird chain, and not taking production down, do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

26%

AI can already do 26% of this job.

#207 / 623

Penetration tester

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Recon, scans and enumeration. Estimate No public source provides a precise figure. This is our estimate.	20%	42%	+8.4
Write the report, evidence and CVSS. Estimate No public source provides a precise figure. This is our estimate.	18%	38%	+6.8
Exploit with judgment and not break the business. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Debrief with the client and retest. Estimate No public source provides a precise figure. This is our estimate.	16%	15%	+2.4
Choose scope, rules and what is off limits. Estimate No public source provides a precise figure. This is our estimate.	14%	16%	+2.2
Research 0-days, labs and keep the craft. Estimate No public source provides a precise figure. This is our estimate.	14%	18%	+2.5
Total	100%		25%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

23%

#311 / 623

Radiation oncologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Contouring, fractions and the dose plan. Estimate No public source provides a precise figure. This is our estimate.	16%	48%	+7.7
Clinic, the tumour and what can be irradiated. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Simulation, immobilisation and the machine day. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Side effects, pauses and the patient who cannot take it. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Board, the surgeon and the medical oncologist. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Signing the plan and the dose that does not erase. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		23%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low